Literature DB >> 14982742

Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease.

Ramon Diaz-Arrastia1, Yunhua Gong, Cynthia J Kelly, Benjamin B Gelman.   

Abstract

The objective of this study was to determine whether host genetic polymorphisms influence the risk of developing human immunodeficiency virus (HIV) encephalitis and vacuolar myelopathy. Allelic association studies were carried out with common polymorphisms in candidate genes that are postulated to play a role in the pathogenesis of HIV-related neurologic complications. The authors studied brains and spinal cords from 270 patients who died of acquired immunodeficiency syndrome (AIDS) from 1989 to 1996. All had complete gross and microscopic pathologic evaluations, and the presence of microglial nodules, multinucleated giant cells, myelin pallor, and vacuolar myelopathy was assessed by an experienced neuropathologist who was blinded to the genotype. DNA was extracted from frozen brain samples, and determination of the presence of the APOE4, TNF-2, IL-1B*2, ILIRN*2 polymorphisms was determined by polymerase chain reaction (PCR) and restricted fragment length polymorphism (RFLP) mapping. The authors did not detect a consistent association between inheritance of candidate polymorphic alleles and the pathologic findings of HIV encephalitis or vacuolar myelopathy. Allelic association studies with candidate genes are powerful techniques that have the potential to contribute to understanding the pathophysiology of HIV-related neurodegeneration. This preliminary study, although including a substantial number of patients, was not sufficiently powered to exclude a modest but clinically significant effects. Future studies will require much larger sample sizes and technical advances to allow screening at larger number of candidate loci.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982742     DOI: 10.1080/753312755

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  42 in total

1.  APOE genotype is a major predictor of long-term progression of disability in MS.

Authors:  J Chapman; S Vinokurov; A Achiron; D M Karussis; K Mitosek-Szewczyk; M Birnbaum; D M Michaelson; A D Korczyn
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

2.  A simple and efficient method for apolipoprotein E genotype determination.

Authors:  J Chapman; J Estupiñan; A Asherov; L G Goldfarb
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

Review 3.  Neuronal injury associated with HIV-1: approaches to treatment.

Authors:  S A Lipton
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

4.  Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

Authors:  F Fazekas; S Strasser-Fuchs; H Kollegger; T Berger; W Kristoferitsch; H Schmidt; C Enzinger; M Schiefermeier; C Schwarz; B Kornek; M Reindl; K Huber; R Grass; G Wimmer; K Vass; K H Pfeiffer; H P Hartung; R Schmidt
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

5.  The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease.

Authors:  R Mayeux; Y Stern; R Ottman; T K Tatemichi; M X Tang; G Maestre; C Ngai; B Tycko; H Ginsberg
Journal:  Ann Neurol       Date:  1993-11       Impact factor: 10.422

6.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

7.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Authors:  E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

8.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy.

Authors:  E H Corder; K Robertson; L Lannfelt; N Bogdanovic; G Eggertsen; J Wilkins; C Hall
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

View more
  12 in total

1.  Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.

Authors:  Andrew J Levine; Susan Service; Eric N Miller; Sandra M Reynolds; Elyse J Singer; Paul Shapshak; Eileen M Martin; Ned Sacktor; James T Becker; Lisa P Jacobson; Paul Thompson; Nelson Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-24       Impact factor: 3.568

Review 2.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 3.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

4.  Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.

Authors:  Virawudh Soontornniyomkij; David J Moore; Ben Gouaux; Benchawanna Soontornniyomkij; Erick T Tatro; Anya Umlauf; Eliezer Masliah; Andrew J Levine; Elyse J Singer; Harry V Vinters; Benjamin B Gelman; Susan Morgello; Mariana Cherner; Igor Grant; Cristian L Achim
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

Review 5.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

6.  Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Authors:  Sergi Veloso; Montserrat Olona; Felipe García; Pere Domingo; Carlos Alonso-Villaverde; Montserrat Broch; Joaquim Peraire; Consuelo Viladés; Montserrat Plana; Enric Pedrol; Miguel López-Dupla; Carmen Aguilar; Mar Gutiérrez; Agathe Leon; Mariona Tasias; Josep Ma Gatell; Cristóbal Richart; Francesc Vidal
Journal:  BMC Med Genet       Date:  2010-04-26       Impact factor: 2.103

Review 7.  The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.

Authors:  Andrew J Levine; Elyse J Singer; Paul Shapshak
Journal:  AIDS Behav       Date:  2008-02-09

8.  Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.

Authors:  Sebastiaan M Bol; Thijs Booiman; Daniëlle van Manen; Evelien M Bunnik; Ard I van Sighem; Margit Sieberer; Brigitte Boeser-Nunnink; Frank de Wolf; Hanneke Schuitemaker; Peter Portegies; Neeltje A Kootstra; Angélique B van 't Wout
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 9.  Aging and Apolipoprotein E in HIV Infection.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

Review 10.  Host genetic factors predisposing to HIV-associated neurocognitive disorder.

Authors:  Asha R Kallianpur; Andrew J Levine
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.